U.S. stocks move: 10x Genomics surged on October 9th due to target price upgrade, Fred Hutchinson collaboration, and spatial genomics.
Bitget异动解读2026/10/09 14:0510x Genomics October 9th Surge Analysis
Keywords: Target Price Raise, Fred Collaboration, Spatial Omics
1. On October 9th, BofA Securities raised the target price for 10x Genomics from $50 to $80 and maintained a hold rating.
2. On October 7th, the company reached a multi-project research collaboration with Fred Hutchinson Cancer Center, utilizing the Flex Apex, Xenium, and upcoming Atera platforms to conduct biomarker discovery in bladder cancer and minimal residual disease detection in acute myeloid leukemia, driving the application of single-cell and spatial technologies into clinical research of solid tumors and hematologic malignancies.
(Disclaimer: This content is generated by AI technology based on public information summary, for reference only and does not constitute investment advice.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
PDVSA official expects to sign 105 oil contracts by the end of the year
Head of Venezuela's national oil company PDVSA: It is expected that 105 oil contracts will be signed by the end of the year.
INE crude oil main contract breaks through 740 yuan/barrel, Brent crude oil rises above 105 USD/barrel
The main contract of China INE crude oil futures has just broken through the 740.0 yuan/barrel mark, now quoted at 740.1 yuan/barrel, down 0.16% on the day. The main contract of Brent crude oil futures has just broken through the $105.00/barrel mark, now quoted at $105.01/barrel, up 1.09% on the day.
Crypto prices
More
